SCHEMBL21812995

SCHEMBL21812995

CC(C)(C)OC(=O)NCc1nc(COS(C)(=O)=O)cs1

nearest known ligand 0.43

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
HDAC3 O15379 3/20 0.43
HDAC1 Q13547 3/20 0.43
HDAC6 Q9UBN7 3/20 0.43
CA12 O43570 2/20 0.41
CA1 P00915 2/20 0.41
CA2 P00918 2/20 0.41
CA9 Q16790 2/20 0.41
PTPRB P23467 6/20 0.39
KDM4A O75164 1/20 0.36
PDPK1 O15530 1/20 0.35
KDM4E B2RXH2 1/20 0.34
LMNA P02545 1/20 0.34
NQO2 P16083 1/20 0.34
L3MBTL1 Q9Y468 1/20 0.34
CACNA1H O95180 1/20 0.34
CACNA1B Q00975 1/20 0.34
CACNA1C Q13936 1/20 0.34
GPR119 Q8TDV5 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8052888 0.85 HDAC3 (0.45) HDAC3HDAC1HDAC6CA12CA1
SCHEMBL8041524 0.82 HDAC3 (0.47) HDAC3HDAC1HDAC6CA12CA1
SCHEMBL18136859 0.82 HDAC3 (0.47) HDAC3HDAC1HDAC6CA12CA1
SCHEMBL8053542 0.81 HDAC3 (0.46) HDAC3HDAC1HDAC6CA12CA1
SCHEMBL17136360 0.81 HDAC3 (0.48) HDAC3HDAC1HDAC6CA12CA1
SCHEMBL17371391 0.81 SIRT1 (0.46) HDAC3HDAC1CA1CA2PTPRB
SCHEMBL18605667 0.80 HDAC3 (0.45) HDAC3HDAC1HDAC6CA12CA1
SCHEMBL28684742 0.79 HDAC3 (0.45) HDAC3HDAC1HDAC6CA12CA1
SCHEMBL16020352 0.77 HDAC3 (0.48) HDAC3HDAC1HDAC6CA12CA1
SCHEMBL215719 0.77 HDAC3 (0.51) HDAC3HDAC1HDAC6CA12CA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020064175-A1 INDANE DERIVATIVES FOR USE IN THE TREATMENT OF BACTERIAL INFECTION ANTABIO SAS (FR) 2020-04-02 WO disclosed
EP-3628672-A1 INDANE DERIVATIVES FOR USE IN THE TREATMENT OF BACTERIAL INFECTION Antabio SAS (FR) 2020-04-01 EP disclosed